Legal Representation
Attorney
Paul Grandinetti
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-05-14)
Due Date
May 14, 2025
Grace Period Ends
November 14, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
25 eventsDate | Code | Type | Description |
---|---|---|---|
May 14, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Apr 12, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
May 14, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Feb 26, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Feb 26, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
Feb 6, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jan 16, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jan 16, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 16, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 15, 2019 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Oct 25, 2018 | CNSL | R | SUSPENSION LETTER WRITTEN |
Oct 25, 2018 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Oct 25, 2018 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
Oct 24, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 24, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 24, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sep 17, 2018 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Sep 13, 2018 | ALIE | A | ASSIGNED TO LIE |
Sep 2, 2018 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Aug 15, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Aug 15, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED |
Aug 15, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
Aug 14, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
May 6, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
May 1, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals, namely, medicines containing endopeptidases; oral peptidases compositions for the treatment of gluten intolerance
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO